Global Leukocyte Surface Antigen CD47 Market By Product Type (B-6H12, ALX-148) And By End-Users/Application (Lymphoma, Ovarian Cancer) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

  • AMR-985455
  • April 2021
  • Pharmaceuticals
  • 115 Pages

Report Preview

The Leukocyte Surface Antigen CD47 Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)

The Leukocyte Surface Antigen CD47 Market has been valued at US$ xx Mn in the year 2020 and is anticipated to attain US$ xx Mn by the year 2028 along with a CAGR of xx%

Leukocyte Surface Antigen CD47 Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Leukocyte Surface Antigen CD47 market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2019
Forecast Period Covered 2019 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Product Type B-6H12, ALX-148, CC-90002, PSTx-23, Others
Applications Lymphoma, Ovarian Cancer, Ischemia Reperfusion Injury, Kindney Transplant Rejection, Others
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, Surface Oncology Inc, Trillium Therapeutics Inc
 
Leukocyte Surface Antigen CD47 Market Competitive and Premeditated Analysis
In the Leukocyte Surface Antigen CD47 report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Leukocyte Surface Antigen CD47 research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Leukocyte Surface Antigen CD47 Market Segmentation Analysis:
The Leukocyte Surface Antigen CD47 market is segmented into various sections such as product types, applications as well as end users and regions. Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

Segmentation based on type includes B-6H12, ALX-148, CC-90002, PSTx-23, Others   

The application segment includes   Lymphoma, Ovarian Cancer, Ischemia Reperfusion Injury, Kindney Transplant Rejection, Others

Major Key Players for Global Leukocyte Surface Antigen CD47 Market:
The Leukocyte Surface Antigen CD47 market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Aurigene Discovery Technologies Ltd, Celgene Corp, Forty Seven Inc, Surface Oncology Inc, Trillium Therapeutics Inc
 
The Leukocyte Surface Antigen CD47 market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Regional Analysis of the Leukocyte Surface Antigen CD47 market:
The Leukocyte Surface Antigen CD47 market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

The Global segmentation of the Leukocyte Surface Antigen CD47 market:
By Type:
  • B-6H12
  • ALX-148
  • CC-90002
  • PSTx-23
  • Others

By Application
  • Lymphoma
  • Ovarian Cancer
  • Ischemia Reperfusion Injury
  • Kindney Transplant Rejection
  • Others

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


 
Major Factors Included and highlighted in the Leukocyte Surface Antigen CD47 report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Leukocyte Surface Antigen CD47 market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Leukocyte Surface Antigen CD47 market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Leukocyte Surface Antigen CD47 market is included in the report.
 
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Leukocyte Surface Antigen CD47 market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Leukocyte Surface Antigen CD47 market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Leukocyte Surface Antigen CD47 market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Leukocyte Surface Antigen CD47 market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Leukocyte Surface Antigen CD47 market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Leukocyte Surface Antigen CD47 Market Snapshot
          2.1.1. Global Leukocyte Surface Antigen CD47 Market By Type,2019
               2.1.1.1.B-6H12
               2.1.1.2.ALX-148
               2.1.1.3.CC-90002
               2.1.1.4.PSTx-23
               2.1.1.5.Others
          2.1.2. Global Leukocyte Surface Antigen CD47 Market By Application,2019
               2.1.2.1.Lymphoma
               2.1.2.2.Ovarian Cancer
               2.1.2.3.Ischemia Reperfusion Injury
               2.1.2.4.Kindney Transplant Rejection
               2.1.2.5.Others
          2.1.3. Global Leukocyte Surface Antigen CD47 Market By End-use,2019
          2.1.4. Global Leukocyte Surface Antigen CD47 Market By Geography,2019

3. Global Leukocyte Surface Antigen CD47 Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Leukocyte Surface Antigen CD47 Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Leukocyte Surface Antigen CD47 Market Size (US$), By Type, 2018 – 2028

5. Global Leukocyte Surface Antigen CD47 Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Leukocyte Surface Antigen CD47 Market Size (US$), By Application, 2018 – 2028

6. Global Leukocyte Surface Antigen CD47 Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Leukocyte Surface Antigen CD47 Market Size (US$), By End-use, 2018 – 2028

7. Global Leukocyte Surface Antigen CD47 Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Leukocyte Surface Antigen CD47 Market Analysis, 2018 – 2028 
          7.2.1. North America Leukocyte Surface Antigen CD47 Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Leukocyte Surface Antigen CD47 Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Leukocyte Surface Antigen CD47 Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Leukocyte Surface Antigen CD47 Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Leukocyte Surface Antigen CD47 Market Analysis, 2018 – 2028 
          7.3.1.  Europe Leukocyte Surface Antigen CD47 Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Leukocyte Surface Antigen CD47 Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Leukocyte Surface Antigen CD47 Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Leukocyte Surface Antigen CD47 Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Leukocyte Surface Antigen CD47 Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Leukocyte Surface Antigen CD47 Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Leukocyte Surface Antigen CD47 Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Leukocyte Surface Antigen CD47 Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Leukocyte Surface Antigen CD47 Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Leukocyte Surface Antigen CD47 Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Leukocyte Surface Antigen CD47 Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Leukocyte Surface Antigen CD47 Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Leukocyte Surface Antigen CD47 Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Leukocyte Surface Antigen CD47 Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Leukocyte Surface Antigen CD47 Market Analysis, 2018 – 2028 
          7.6.1.  MEA Leukocyte Surface Antigen CD47 Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Leukocyte Surface Antigen CD47 Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Leukocyte Surface Antigen CD47 Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Leukocyte Surface Antigen CD47 Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Leukocyte Surface Antigen CD47 Providers
        8.4.1 Aurigene Discovery Technologies Ltd
                8.1.1 Business Description
                8.1.2 Aurigene Discovery Technologies Ltd Geographic Operations
                8.1.3 Aurigene Discovery Technologies Ltd Financial Information
                8.1.4 Aurigene Discovery Technologies Ltd Product Positions/Portfolio
                8.1.5 Aurigene Discovery Technologies Ltd Key Developments
        8.4.2 Celgene Corp
                8.2.1 Business Description
                8.2.2 Celgene Corp Geographic Operations
                8.2.3 Celgene Corp Financial Information
                8.2.4 Celgene Corp Product Positions/Portfolio
                8.2.5 Celgene Corp Key Developments
        8.4.3 Forty Seven Inc
                8.3.1 Business Description
                8.3.2 Forty Seven Inc Geographic Operations
                8.3.3 Forty Seven Inc Financial Information
                8.3.4 Forty Seven Inc Product Positions/Portfolio
                8.3.5 Forty Seven Inc Key Developments
        8.4.4 Surface Oncology Inc
                8.4.1 Business Description
                8.4.2 Surface Oncology Inc Geographic Operations
                8.4.3 Surface Oncology Inc Financial Information
                8.4.4 Surface Oncology Inc Product Positions/Portfolio
                8.4.5 Surface Oncology Inc Key Developments
        8.4.5 Trillium Therapeutics Inc
                8.5.1 Business Description
                8.5.2 Trillium Therapeutics Inc Geographic Operations
                8.5.3 Trillium Therapeutics Inc Financial Information
                8.5.4 Trillium Therapeutics Inc Product Positions/Portfolio
                8.5.5 Trillium Therapeutics Inc Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Leukocyte Surface Antigen CD47 Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Leukocyte Surface Antigen CD47 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Leukocyte Surface Antigen CD47 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Leukocyte Surface Antigen CD47 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Leukocyte Surface Antigen CD47 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Leukocyte Surface Antigen CD47 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Leukocyte Surface Antigen CD47 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Leukocyte Surface Antigen CD47 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Leukocyte Surface Antigen CD47 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Leukocyte Surface Antigen CD47 Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Leukocyte Surface Antigen CD47 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Leukocyte Surface Antigen CD47 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Leukocyte Surface Antigen CD47 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Leukocyte Surface Antigen CD47 Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Leukocyte Surface Antigen CD47 Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Leukocyte Surface Antigen CD47 Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Leukocyte Surface Antigen CD47: Market Segmentation 
FIG. 2 Global Leukocyte Surface Antigen CD47 Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Leukocyte Surface Antigen CD47 Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Leukocyte Surface Antigen CD47 Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Leukocyte Surface Antigen CD47 Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Leukocyte Surface Antigen CD47 Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Leukocyte Surface Antigen CD47 Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Leukocyte Surface Antigen CD47 Providers, 2019
FIG. 11 Global Leukocyte Surface Antigen CD47 Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Leukocyte Surface Antigen CD47 Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Leukocyte Surface Antigen CD47 Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Leukocyte Surface Antigen CD47 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Leukocyte Surface Antigen CD47 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Leukocyte Surface Antigen CD47 Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Leukocyte Surface Antigen CD47 Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Leukocyte Surface Antigen CD47 Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Leukocyte Surface Antigen CD47 market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Leukocyte Surface Antigen CD47 Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Leukocyte Surface Antigen CD47 Market Value, By Segment1, 2018 – 2028
TABLE  North America Leukocyte Surface Antigen CD47 Market Value, By Segment2, 2018 – 2028
TABLE  North America Leukocyte Surface Antigen CD47 Market Value, By Country, 2018 – 2028
TABLE  Europe Leukocyte Surface Antigen CD47 Market Value, By Segment1, 2018 – 2028
TABLE  Europe Leukocyte Surface Antigen CD47 Market Value, By Segment2, 2018 – 2028
TABLE  Europe Leukocyte Surface Antigen CD47 Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Leukocyte Surface Antigen CD47 Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Leukocyte Surface Antigen CD47 Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Leukocyte Surface Antigen CD47 Market Value, By Country, 2018 – 2028
TABLE  Latin America Leukocyte Surface Antigen CD47 Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Leukocyte Surface Antigen CD47 Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Leukocyte Surface Antigen CD47 Market Value, By Country, 2018 – 2028
TABLE  MEA Leukocyte Surface Antigen CD47 Market Value, By Segment1, 2018 – 2028
TABLE  MEA Leukocyte Surface Antigen CD47 Market Value, By Segment2, 2018 – 2028
TABLE  MEA Leukocyte Surface Antigen CD47 Market Value, By Country, 2018 – 2028
TABLE  Aurigene Discovery Technologies Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Celgene Corp: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Forty Seven Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Surface Oncology Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Trillium Therapeutics Inc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Leukocyte Surface Antigen CD47 Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Leukocyte Surface Antigen CD47 Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Leukocyte Surface Antigen CD47 Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Leukocyte Surface Antigen CD47 Market, By Geography, 2019 (US$ Mn)
FIG.  Global Leukocyte Surface Antigen CD47 Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Leukocyte Surface Antigen CD47 Providers, 2016
FIG.  Global Leukocyte Surface Antigen CD47 Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global B-6H12 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global ALX-148 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global CC-90002 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global PSTx-23 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Leukocyte Surface Antigen CD47 Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Lymphoma Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Ovarian Cancer Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Ischemia Reperfusion Injury Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Kindney Transplant Rejection Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Leukocyte Surface Antigen CD47 Market Value, 2018 – 2028, (US$ Mn)